{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:57:57Z","timestamp":1771235877383,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T00:00:00Z","timestamp":1310601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p>\n                    <jats:bold>What\u2019s known on the subject? and What does the study add?<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>\n                    Although synthetic mid\u2010urethral slings are now generally accepted as the first\u2010line surgical treatment of female stress incontinence, there is concern that newer slings are being used prematurely, before sufficient evidence exists. The 3\n                    <jats:sup>rd<\/jats:sup>\n                    generation \u201cmini\u2010slings\u201d are inserted via a single incision which, theoretically, reduces iatrogenic morbidity. It is vital, however, that efficacy is not compromised. To date, a number of papers have examined short\u2010term outcome data following the TVT\u2010Secur, with wide variations in reported cure rates at up to one year.\n                  <\/jats:p>\n                  <jats:p>\n                    This is the largest review of outcomes following TVT\u2010Secur published to date (\n                    <jats:italic>n<\/jats:italic>\n                    = 1178 cases from 10 studies). Cure rate, both objectively and subjectively, was 76%, which is similar to more established mid\u2010urethral slings. Intra\u2010operative vaginal perforation rates and rates of mesh exposure in the first 12 months post\u2010operatively were both 2%. The incidence of\n                    <jats:italic>de novo<\/jats:italic>\n                    OAB was 10%. No serious complications were recorded amongst this large cohort. Although the TVT\u2010Secur appears to be a safe procedure, its long\u2010term efficacy moving forward requires close scrutiny.\n                  <\/jats:p>\n                  <jats:p>\u2022\u2002Synthetic mid\u2010urethral slings (MUSs) are considered the first choice surgical procedure for stress urinary incontinence. Recent publications have raised concerns about the efficacy of third generation single\u2010incision mini\u2010slings. The present paper is a systematic review of studies reporting 12\u2010month outcomes after the TVT\u2010Secur (TVT\u2010S) procedure.<\/jats:p>\n                  <jats:p>\n                    \u2022\u2002Pubmed\/Medline online databases, abstracts from recent International Continence Society and International Urogynecological Association annual scientific meetings and the\n                    <jats:italic>Clinicaltrials.gov<\/jats:italic>\n                    and\n                    <jats:italic>Controlled\u2010trials.com<\/jats:italic>\n                    online trial registries were searched for English\u2010language articles containing the terms \u2018TVT\u2010Secur\u2019, \u2018TVT Secur\u2019 or \u2018mini\u2010sling\u2019. The primary outcomes were objective and subjective cure rates at 12 months. Secondary outcomes included peri\u2010operative (vaginal perforation, urinary retention, urinary tract infection [UTI]) and postoperative (mesh exposure,\n                    <jats:italic>de novo<\/jats:italic>\n                    overactive bladder (OAB), dyspareunia and return to theatre) complication rates.\n                  <\/jats:p>\n                  <jats:p>\n                    \u2022\u2002Among 1178 women undergoing the TVT\u2010S procedure, from 10 studies, both objective and subjective cure rate at 12 months was 76%, with objective cure significantly higher in women undergoing the \u2018U\u2010type\u2019 approach. Vaginal perforation was a complication in 1.5% of cases, with a 2.4% incidence of mesh exposure in the first year. The incidence of\n                    <jats:italic>de novo<\/jats:italic>\n                    OAB symptoms was 10%. Rates of urinary retention (2.3%), UTI (4.4%), dyspareunia (1%) and return to theatre for complications (0.8%) were low. In the first year after a TVT\u2010S procedure 5% of women required repeat continence surgery.\n                  <\/jats:p>\n                  <jats:p>\u2022\u2002Longer\u2010term studies and randomized comparisons with more established MUSs are required before TVT\u2010S should be routinely used in the surgical treatment of stress urinary incontinence.<\/jats:p>","DOI":"10.1111\/j.1464-410x.2011.10333.x","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T08:52:51Z","timestamp":1310633571000},"page":"652-657","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["TVT\u2010Secur mini\u2010sling for stress urinary incontinence: a review of outcomes at 12 months"],"prefix":"10.1111","volume":"108","author":[{"given":"Colin A.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,14]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006375.pub2"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01902378"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-008-0062-8"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.04.021"},{"key":"e_1_2_8_6_2","unstructured":"National Institute for Health and Clinical Excellence.Interventional procedure guidance 262. Single\u2010incision sub\u2010urethral short tape insertion for stress urinary incontinence in women. May 2008. NICE London UK. Available at:http:\/\/www.nice.org.uk\/guidance\/IPG262\/PublicInfo\/pdf\/English. Accessed January 2011"},{"issue":"1","key":"e_1_2_8_7_2","first-page":"S11","article-title":"TVT SecurTM: prospective study and follow up to 1 year about 150 patients","volume":"19","author":"Debodinance P","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2010.51.4.250"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-010-1128-y"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.07.013"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.02.018"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-008-0772-y"},{"issue":"3","key":"e_1_2_8_13_2","first-page":"S274","article-title":"One year outcomes for TVT\u2010Secur","volume":"20","author":"Molden SM","year":"2009","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2008.04.006"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08330.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-010-1181-6"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.04.022"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912658"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.08.004"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.10.066"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.01.061"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-010-1103-7"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-008-0615-x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2010.14.4.275"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-009-0886-x"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2011.10333.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2011.10333.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:23:33Z","timestamp":1761758613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2011.10333.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1464-410X.2011.10333.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2011.10333.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,14]]},"assertion":[{"value":"2011-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}